231 related articles for article (PubMed ID: 24308582)
21. H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
Adami EA; Chavez Rico SL; Akamatsu MA; Miyaki C; Raw I; de Oliveira D; Comone P; Oliveira RDN; Sarno de Oliveira ML; Estima Abreu PA; Takano CY; Meros M; Soares-Schanoski A; Lee Ho P
Biochem Biophys Res Commun; 2021 Mar; 545():145-149. PubMed ID: 33550095
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
Kim JI; Park S; Bae JY; Lee S; Kim J; Kim G; Yoo K; Heo J; Kim YS; Shin JS; Park MS; Park MS
PLoS Biol; 2020 Dec; 18(12):e3001024. PubMed ID: 33362243
[TBL] [Abstract][Full Text] [Related]
23. ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
Chung KY; Coyle EM; Jani D; King LR; Bhardwaj R; Fries L; Smith G; Glenn G; Golding H; Khurana S
Vaccine; 2015 Jul; 33(32):3953-62. PubMed ID: 26093202
[TBL] [Abstract][Full Text] [Related]
24. Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.
Yang X; Zhao J; Wang C; Duan Y; Zhao Z; Chen R; Zhang L; Xing L; Lai C; Zhang S; Wang X; Yang P
PLoS One; 2015; 10(4):e0123659. PubMed ID: 25884801
[TBL] [Abstract][Full Text] [Related]
25. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
[TBL] [Abstract][Full Text] [Related]
26. Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat.
Pierce CL; Williams TL; Santana WI; Levine M; Chen LM; Cooper HC; Solano MI; Woolfitt AR; Marasco WA; Fang H; Donis RO; Barr JR
Vaccine; 2017 Sep; 35(37):5011-5018. PubMed ID: 28774565
[TBL] [Abstract][Full Text] [Related]
27. Preparing for a potential A(H7N9) pandemic: lessons from the deployment of A(H1N1) pandemic vaccines.
Nguyen-Van-Tam JS; Sellwood C
Expert Rev Vaccines; 2013 Aug; 12(8):825-8. PubMed ID: 23984955
[No Abstract] [Full Text] [Related]
28. Protection against influenza H7N9 virus challenge with a recombinant NP-M1-HSP60 protein vaccine construct in BALB/c mice.
Yang P; Wang W; Gu H; Li Z; Zhang K; Wang Z; Li R; Duan Y; Zhang S; Wang X
Antiviral Res; 2014 Nov; 111():1-7. PubMed ID: 25173575
[TBL] [Abstract][Full Text] [Related]
29. Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
Gravel C; Elmgren C; Muralidharan A; Hashem AM; Jaentschke B; Xu K; Widdison J; Arnold K; Farnsworth A; Rinfret A; Van Domselaar G; Wang J; Li C; Li X
Vaccine; 2015 Feb; 33(9):1129-34. PubMed ID: 25620245
[TBL] [Abstract][Full Text] [Related]
30. Willingness of future A/H7N9 influenza vaccine uptake: A cross-sectional study of Hong Kong community.
Chan EY; Cheng CK; Tam GC; Huang Z; Lee PY
Vaccine; 2015 Sep; 33(38):4737-40. PubMed ID: 26226564
[TBL] [Abstract][Full Text] [Related]
31. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
Henry Dunand CJ; Leon PE; Kaur K; Tan GS; Zheng NY; Andrews S; Huang M; Qu X; Huang Y; Salgado-Ferrer M; Ho IY; Taylor W; Hai R; Wrammert J; Ahmed R; García-Sastre A; Palese P; Krammer F; Wilson PC
J Clin Invest; 2015 Mar; 125(3):1255-68. PubMed ID: 25689254
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus.
Xu Q; Chen Z; Cheng X; Xu L; Jin H
PLoS One; 2013; 8(10):e76884. PubMed ID: 24130801
[TBL] [Abstract][Full Text] [Related]
33. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
[TBL] [Abstract][Full Text] [Related]
34. Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.
Bertran K; Sá E Silva M; Pantin-Jackwood MJ; Swayne DE
Vaccine; 2013 Aug; 31(35):3572-6. PubMed ID: 23707445
[TBL] [Abstract][Full Text] [Related]
35. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
[No Abstract] [Full Text] [Related]
36. Research progress in human infection with avian influenza H7N9 virus.
Tang J; Wang D
Sci China Life Sci; 2017 Dec; 60(12):1299-1306. PubMed ID: 29270791
[TBL] [Abstract][Full Text] [Related]
37. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
Rudenko L; Isakova-Sivak I
Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
[TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
Vesikari T; Forstén A; Herbinger KH; Cioppa GD; Beygo J; Borkowski A; Groth N; Bennati M; von Sonnenburg F
Vaccine; 2012 Feb; 30(7):1388-96. PubMed ID: 22192847
[TBL] [Abstract][Full Text] [Related]
39. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
[TBL] [Abstract][Full Text] [Related]
40. A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine.
Gou X; Wu X; Shi Y; Zhang K; Huang J
Hum Vaccin Immunother; 2020; 16(2):286-294. PubMed ID: 31419167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
